First coverage batch · 12 distinct issuer reviews · unissued CIN research
Read the business. Reconcile the equity.
Original-source research across twelve issuers from the remaining listing queue. Listing changes, financing, cash conversion and diluted ownership are checked before a proposed rating or target can advance.
NotRated: the live Aurora cash-and-share offer, later cash/debt settlements and post-split capital bridge are not yet reconciled. The numerical scenarios are business EV sensitivities only; no current equity target or upside qualifies.
NotRated: the October10 RYTHM consolidation is a material change in valuation scope, and a consolidated cash/debt/minority/share bridge plus compatible quote is not yet verified. Business EV sensitivities are retained as review work, not current share-price targets.
NotRated: the release’s fully converted count is not yet reconciled to filed capital classes/LLC units, and pending TopCo actions plus substantial cash claims prevent a supported current share target. Conditional business EV scenarios remain review material.
NotRated: expensive secured and convertible claims, disputed tax exposure and a current diluted-share bridge need resolution before a defensible equity target. The business EV sensitivities are not share prices; the authorized consolidation is not treated as implemented.
June accounts precede material September/October investment and preferred financing. Conditional values are model illustrations; final cash, draws, preferred settlement and current diluted share/settlement basis are not reconciled well enough to issue a current target.
Large tax/lease/financial claims and current award/split/financing uncertainties prevent a supported current equity target. Conditional stress values deliberately do not become a Sell rating or a zero target.
Correct OTCQB identity differs from the saved feed venue, while taxes, restricted cash, amended preferred claims, current awards and pending split actions remain material. No supported current quote-adjusted price target is issued.
Nasdaq identity is stale, no corrected current quote is available, and the Up-C/TRA/ClassP capital bridge remains incomplete. Source-verified research can be added while the current rating/target stays NotRated.
NotRated: the conditional equity model is reproducible, but the current same-security post-split quote mapping remains unverified. June-to-horizon cash, tax settlement and future units are assumptions. USD4.03 base (USD4.00 rounded) is conditional model value only, not a CIN target or a Sell recommendation.
Current pro forma cash, gross principal, finance/operating lease changes, tax claims, earnouts, convertible instruments and fully diluted SVS-equivalent units across the acquisition program are not reconciled. The stored quote alone cannot cure this equity-bridge gap.
Pending stock merger and unresolved Vireo fully diluted/pro forma bridge preclude a supported12-month per-share target. Conditional contract math is not a CIN fair-value target; date-only PLNH quote cannot support an executable arbitrage spread.
No compatible current NYSE GLAS quote is supplied, and June capital must be rolled through ATM issuance, exercised warrants, compensation, preferred/convertible claims and the changed retail perimeter. Preliminary cash does not provide a current unrestricted/full financing bridge.
CIN original research · CURLF
Curaleaf Holdings, Inc.
OTCQX · USD
NotRated · target withheld
High risk · unissued draft Model date 2026-10-23
Listing identity and market-data check
Legal domicile
British Columbia, Canada (as identified in the reviewed June accounts)
Business geography
United States and international medical-cannabis operations
Security
Subordinate Voting Shares; one vote per share
Verified listings
ticker CURLF; venue OTCQX Best Market; quote currency USD; ticker CURA; directory alias CURA.TO; venue Toronto Stock Exchange; quote currency CAD
Class bridge
The issuer identifies both CURA and CURLF as its Subordinate Voting Shares. Multiple Voting Shares convert one-for-one into SVS and carry fifteen votes; economic units must include them.
Share adjustment
The June accounts retrospectively reflect the completed 1-for-3 SVS and MVS reverse split of June 5, 2026.
Quote status
No compatible current quote admitted. The stored CURLF observation carried an inconsistent CSE venue. The separate CAD CURA.TO observation is not a USD quote or a current FX bridge.
Source ids
CURA-Q2; CURA-OFFER
Not established in this review.
Current gate: NotRated: the live Aurora cash-and-share offer, later cash/debt settlements and post-split capital bridge are not yet reconciled. The numerical scenarios are business EV sensitivities only; no current equity target or upside qualifies.
Curaleaf offers a combination of US retail/wholesale scale and a separate international medical channel. H1 international revenue rose from USD75.831m to USD98.648m, while the total group generated USD50.244m of operating cash. That supports a real operating case rather than a default score.
Equity value depends on cash claims and capital allocation. The USD82.290m H1 net profit includes a USD137.489m tax benefit against a USD54.937m pre-tax loss; it is not a recurring earnings run rate. USD32.915m of PPE spending, USD50.539m cash interest, the Four20 minority buyout and acquisition consideration compete for cash.
The current Aurora offer changes the investment question. A 0.4013-share plus USD1-cash exchange for each target share must be modelled with the target share count, funding, deal conditions, combined debt and verified synergies. Neither the offered USD5 implied consideration nor a bidder premium is a CIN valuation.
Principal risks and downside mechanism
Current debt is not just the USD619.266m notes principal: finance leases and failed-sale leasebacks create further economic financing claims, and uncertain tax liabilities were USD468.485m at June30. Classify these against a rent-consistent earnings measure before subtracting them; do not double count rent and lease principal.
The USD12m EWB facility matured August25 under the June note. Its actual renewal or repayment after the accounts is not established here. The USD500m senior notes and Needham extension improve part of the maturity ladder but do not answer this later short-term event.
Four20 became wholly owned in April, but USD14.2m of consideration was deferred to August31 and November30. June balances must not be treated as October cash after settlement without an explicit roll-forward.
Aurora bid success, rejection, cash funding and dilution remain uncertain. The October19 statement is the bidder’s advocacy, not independent confirmation of synergies or a completed combination.
June counts already reflect the1-for3 split. Mixing old unsplit units, the CAD TSX quote or the venue-conflicted USD quote would produce a false per-share value. Control, medical/adult-use tax differences, source-date gaps and price compression add risk.
Valuation and financing bridge
Conditional standalone EV/EBITDA sensitivity; equity conversion held
Sourced anchors and model inputs
Company q2 adjusted EBITDA USD million
70.123
Company h1 adjusted EBITDA USD million
133.536
Historical reference source id
CURA-Q2
Assumption label
CIN-selected next12-month operating sensitivities, not company guidance or analyst consensus
Cash, debt, leases, minority and diluted-equity treatment
Cash USD million
94.588
Restricted cash not added USD million
12.38
Notes priNCIpal USD million
619.266
Finance leases USD million
167.681
Failed sale leaseback obligations USD million
205.569
Operating lease pv USD million
129.988
Uncertain tax liability USD million
468.485
Bridge date
2026-06-30
Current share denominator
Unavailable
Equity bridge complete
0
CIN scenarios — assumptions, not company guidance
All forecast inputs and selected multiples below are CIN assumptions. Monetary bridge amounts are in the stated currency and units; per-share values are identified separately. Conditional values in NotRated cases are not current price targets.
Model line / unit
Bear
Base
Bull
Annual EBITDA USD million
240
280
320
Selected EV EBITDA multiple
5
6
7
Enterprise value USD million
1,200
1,680
2,240
Equity value USD million
Unavailable
Unavailable
Unavailable
Per share value
Unavailable
Unavailable
Unavailable
Scope
Curaleaf standalone, excluding completion of Aurora bid
Curaleaf standalone, excluding completion of Aurora bid
Curaleaf standalone, excluding completion of Aurora bid
Label
Conditional business-value sensitivity; not a share-price target
Conditional business-value sensitivity; not a share-price target
Conditional business-value sensitivity; not a share-price target
CIN assumptions
USD240/280/320m EBITDA and5/6/7x are selected downside/base/upside stress inputs. They are not observed peer medians.
Business EVs of USD1,200/1,680/2,240m are before debt-like, minority, tax and deal claims. No share target is produced.
The accounting treatment of finance/failed-sale leasebacks must be aligned with cash rent before an equity valuation; no mechanical all-lease double deduction.
Do not add expected Aurora cash, synergies or issuance as if the offer has completed.
Model limits and missing proof
Pending Aurora transaction and unverified post-June cash/debt/share roll-forward
August25 facility outcome and deferred acquisition payments not reconciled
Tax/rent/financing claim convention and current native-currency quote remain release gates
Next tests and thesis breakers
Original Q3 accounts that reconcile June cash, tax balances, debt maturities and deferred Four20 payments.
Formal Aurora offer outcomes and a financing/share-issuance bridge; no assumed deal closing or synergy in this case.
Cash conversion from international growth, measured against inventory, working capital and local regulatory costs.
Authoritative venue/class/share-adjustment and dated native-currency quote verification before any total-return opinion.
Author holdings, issuer relationships/payments, recent or intended trades and conflicts have not been disclosed. They are not recorded as “none.”
CIN original research · GTBIF
Green Thumb Industries Inc.
OTCQX · USD
NotRated · target withheld
High risk · unissued draft Model date 2026-10-23
Listing identity and market-data check
Legal domicile
British Columbia, Canada
Business geography
US cannabis operations; RYTHM consolidation begins October10 under the reviewed8-K
Security
Subordinate Voting Shares
Verified listings
ticker GTBIF; venue OTCQX Best Market; quote currency USD; ticker GTII; venue Canadian Securities Exchange; quote currency CAD
Class bridge
One Multiple Voting Share converts to100 SVS; one Super Voting Share converts to100 SVS despite carrying1,000 votes. Votes are not economic units.
Quote status
No current quote admitted. Stored GTBIF USD observation is stamped CSE. Issuer historical page gives a dollar price but its parsed symbol selection does not establish which of the two listings was selected.
Source ids
GTI-Q2; GTI-Q2-RELEASE; GTI-QUOTE
Not established in this review.
Current gate: NotRated: the October10 RYTHM consolidation is a material change in valuation scope, and a consolidated cash/debt/minority/share bridge plus compatible quote is not yet verified. Business EV sensitivities are retained as review work, not current share-price targets.
Green Thumb has substantial revenue, operating cash generation and a sizeable cash balance. H1 revenue was USD606.873m and operating cashUSD104.810m, against PPE purchasesUSD39.077m. This operating record merits fresh primary-source coverage.
The economic lens matters more than the headline metric. The Q2 adjusted EBITDA ofUSD68.564m includes brand fees, while the company’s higher normalized measure adds them back. The legacy standalone case must retain the recurring licence cost rather than assume it disappears from cash earnings.
The October10 RYTHM consolidation creates a new reporting boundary. The company’s August11 original8-K explicitly requires consolidation, even without exercising securities. A current group valuation must eliminate intercompany fees and notes, add RYTHM’s external economics and cash claims, and measure outside ownership. It cannot add a separately valued RYM stake to consolidated earnings.
Principal risks and downside mechanism
Pre-consolidation GTI financials do not constitute October consolidated results. The licence expense cannot simply be added back without simultaneously including RYTHM external costs and non-controlling claims.
H1 cash taxes ofUSD10.588m were well belowUSD60.613m tax expense; the balance sheet carriesUSD203.454m unrecognized tax benefits andUSD24.994m current tax payable. Neither tax relief nor a permanent low cash tax rate is assumed.
A July30 basic common-equivalent count is not today’s fully diluted share count. June options and RSUs, subsequent buybacks and award settlements require a single-date roll-forward. The SeptemberUSD50m authorization is not a completed cash outflow or a reduction in units.
USD30.250m acquisition consideration and operating lease obligations remain real claims; the cash balance is not all excess cash. Book minority value is not automatically fair value.
The cached GTBIF row has an inconsistent venue. A false OTC/CSE match would contaminate market cap, target comparisons and return calculations; US federal restrictions and state pricing competition remain operating risks.
Valuation and financing bridge
Conditional legacy standalone EV/EBITDA sensitivity; post-consolidation equity target held
Sourced anchors and model inputs
Q2 standalone adjusted EBITDA USD million
68.564
Q2 annualized arithmetic reference USD million
274.256
Fixed annual licence USD million
70
Historical reference source id
GTI-Q2
Assumption label
CIN stress inputs for the legacy standalone scope, not an October consolidated forecast
Cash, debt, leases, minority and diluted-equity treatment
Bridge date
2026-06-30
Cash USD million
283.586
Debt priNCIpal before discounts USD million
285.549
Acquisition payable USD million
30.25
Current tax payable USD million
24.994
Unrecognized tax benefits USD million
203.454
Operating lease pv USD million
277.195
July30 basic common equivalents
218,588,782
Current share denominator
Unavailable
Equity bridge complete
0
CIN scenarios — assumptions, not company guidance
All forecast inputs and selected multiples below are CIN assumptions. Monetary bridge amounts are in the stated currency and units; per-share values are identified separately. Conditional values in NotRated cases are not current price targets.
Model line / unit
Bear
Base
Bull
Annual EBITDA USD million
250
285
320
Selected EV EBITDA multiple
5
6
7
Enterprise value USD million
1,250
1,710
2,240
Equity value USD million
Unavailable
Unavailable
Unavailable
Per share value
Unavailable
Unavailable
Unavailable
Scope
Legacy GTI standalone after operating rent and brand fees; excludes the required newRYTHM consolidation bridge
Legacy GTI standalone after operating rent and brand fees; excludes the required newRYTHM consolidation bridge
Legacy GTI standalone after operating rent and brand fees; excludes the required newRYTHM consolidation bridge
Label
Conditional business-value sensitivity; not a share-price target
Conditional business-value sensitivity; not a share-price target
Conditional business-value sensitivity; not a share-price target
CIN assumptions
USD250/285/320m EBITDA with5/6/7x yields USD1,250/1,710/2,240m business EVs; selected multiples are not a reported peer median.
These sensitivities retain standalone recurring licence fees and operating rent. Do not present them as October consolidated forecasts.
For a completed consolidated model, intercompany licence fees and notes must be eliminated alongside inclusion ofRYTHM external operations, liabilities and outside shareholders.
No RYTHM investment value, buyback authorization or unsupported tax recovery is added to equity.
Model limits and missing proof
Required October10 consolidation not bridged to current cash, external debt, costs and minority interests
Single-date fully diluted units and current quote not qualified
Uncertain tax and lease treatment prevent a mechanical headline EBITDA-to-target shortcut
Next tests and thesis breakers
The first original post-October10 consolidated RYTHM financial bridge, with related-party eliminations, external cash/debt and minority interests.
Next quarter’s recurring cash conversion after taxes, brand economics and maintenance/expansion spending are separated.
Actual completed buyback and equity-award disclosures that roll July units to the model date.
An exact OTCQX GTBIF USD quote with original date and share basis, independently matched to the reviewed listing.
Stored CRLBF USD quote is stamped CSE; no qualified exact-venue current quote admitted.
Source ids
CRL-Q2; CRL-RELEASE; CRL-CIRCULAR; CRL-SUPPLEMENT
Not established in this review.
Current gate: NotRated: the release’s fully converted count is not yet reconciled to filed capital classes/LLC units, and pending TopCo actions plus substantial cash claims prevent a supported current share target. Conditional business EV scenarios remain review material.
Cresco’s wholesale brands and Sunnyside retail channel provide a real operating platform. Q2 revenue ofUSD173.341m and company adjusted EBITDA ofUSD39.539m show an improved sequential quarter, but H1 cash conversion remains the main underwriting test.
H1 operating cash ofUSD9.794m did not cover USD16.926m PPE purchases, before USD3.975m intangible purchases and acquisition cash. The headline USD67.365m total cash includes restricted amounts; onlyUSD32.872m is unrestricted cash and equivalents.
A meaningful capital simplification is proposed for an October30 shareholder meeting. A newTopCo, later Delaware redomicile and discretionary reverse split could change the security identity and denominator. Until implementation and the economic share bridge are reconciled, a corporate action catalyst is not an uplisting or value creation already achieved.
Principal risks and downside mechanism
The issuer release reports506.844777m fully converted SVS, whereas the original filed tables separately show subordinate, as-converted proportionate, super-voting, special and84.299m redeemable LLC units. The scope and incremental award dilution must be reconciled; do not choose a convenient denominator.
Restricted cash and a USD50m revolver commitment cannot be treated as unrestricted cash. Only the actualUSD1.411m revolver drawing is reported here; borrowing availability depends on conditions and is not extra equity.
Financing/property obligations, acquisition consideration, the USD66.118m tax-receivable agreement liability andUSD194.733m uncertain tax position can consume residual value beyond headline bank debt. Operating and financing leases need a consistent rent treatment.
A negative NCI book balance is not a cash asset and must not be added to equity. If redeemable LLC units are included as common equivalents, the same exchangeable economics must not also be deducted as a full minority claim.
A Q2 tax benefit helped reported profit; expected medical tax changes are not blanket forgiveness of historic or adult-use taxes. The interim CFO transition and proposed voting-right amendment also deserve governance review.
Valuation and financing bridge
Conditional EV/EBITDA sensitivity; financing and converted-unit bridge held
Sourced anchors and model inputs
Company q2 adjusted EBITDA USD million
39.539
Q2 annualized arithmetic reference USD million
158.156
Historical reference source id
CRL-RELEASE
Assumption label
CIN-selected operating stress cases, not guidance or externally surveyed estimates
Cash, debt, leases, minority and diluted-equity treatment
Bridge date
2026-06-30
Unrestricted cash USD million
32.872
Restricted cash total not added USD million
34.493
Senior term priNCIpal USD million
325
Revolver drawn USD million
1.411
Mortgage amount USD million
19.955
FinaNCIng liability USD million
89.402
Finance lease liabilities USD million
19.588
Operating lease pv USD million
141.55
Acquisition consideration USD million
56.636
Tax receivable agreement USD million
66.118
Uncertain tax liability USD million
194.733
Current share denominator
Unavailable
Equity bridge complete
0
CIN scenarios — assumptions, not company guidance
All forecast inputs and selected multiples below are CIN assumptions. Monetary bridge amounts are in the stated currency and units; per-share values are identified separately. Conditional values in NotRated cases are not current price targets.
Model line / unit
Bear
Base
Bull
Annual EBITDA USD million
130
155
180
Selected EV EBITDA multiple
4
5
6
Enterprise value USD million
520
775
1,080
Equity value USD million
Unavailable
Unavailable
Unavailable
Per share value
Unavailable
Unavailable
Unavailable
Scope
Existing Cresco operations; pending TopCo structure not assumed completed
Existing Cresco operations; pending TopCo structure not assumed completed
Existing Cresco operations; pending TopCo structure not assumed completed
Label
Conditional business-value sensitivity; not a share-price target
Conditional business-value sensitivity; not a share-price target
Conditional business-value sensitivity; not a share-price target
CIN assumptions
USD130/155/180m annual EBITDA at4/5/6x gives USD520/775/1,080m business EVs before debt-like, tax, minority and acquisition claims.
Multiples are CIN judgemental sensitivities, not verified peer medians. No per-share result is computed.
Reconcile property-financing debt and economic rent consistently; avoid deducting an operating lease PV after capitalizing earnings that already include its rent.
No uplift from a future US listing or future tax refund is assumed.
Model limits and missing proof
Unreconciled fully-converted count against original filed capital classes and awards
Liquidity, tax-receivable and lease/financing waterfall plus exact quote remain current-target gates
Next tests and thesis breakers
October30 vote and any actual closing, listing notices, reverse-split ratio and TopCo exchange documentation.
A single-date capitalization table reconciling506.844777m release units to original share classes, redeemable LLC units, awards and pending acquisition shares.
Positive recurring operating cash after cash taxes, maintenance spending, acquisition installments and tax-receivable payments.
Original Q3 financial statements showing cash restrictions, revolving availability, covenant compliance and acquisition integration.
Author holdings, issuer relationships/payments, recent or intended trades and conflicts have not been disclosed. They are not recorded as “none.”
CIN original research · TSNDF
TerrAscend Corp.
OTCQX · USD
NotRated · target withheld
High risk · unissued draft Model date 2026-10-23
Listing identity and market-data check
Legal domicile
Ontario, Canada
Business geography
US continuing cannabis operations and Canadian retail; formerMichigan operations presented separately
Security
Common Shares, with exchangeable and convertible preferred shares requiring economic conversion
Verified listings
ticker TSNDF; venue OTCQX Best Market; quote currency USD; ticker TSND; venue Toronto Stock Exchange; quote currency CAD
Quote status
Stored TSNDF USD observation is stamped CSE; no independently qualified exact-venue current quote admitted.
Source ids
TSND-Q2; TSND-RELEASE; TSND-VOTE
Not established in this review.
Current gate: NotRated: expensive secured and convertible claims, disputed tax exposure and a current diluted-share bridge need resolution before a defensible equity target. The business EV sensitivities are not share prices; the authorized consolidation is not treated as implemented.
The continuing business has a measurable cash-generation record: H1 revenueUSD132.658m, continuing operating cashUSD16.037m and PPE spendingUSD2.504m. A tighter core after theMichigan exit can improve the quality of cash conversion without assuming a new market opens.
Financing is expensive relative to the scale of the business. The principal loan balance ofUSD209.682m exceeds itsUSD197.275m carrying amount, and convertible face principal must be considered rather than only the discounted liability on the balance sheet.
TheJune2031 debenture refinancing removes part of a near-term maturity, but creates a choice between cash interest and future conversion/PIK dilution. US listing preparation is an option; the August shareholder authorization is not a completed split or a national-exchange listing.
Principal risks and downside mechanism
The largest secured loan bears12.75% and has a2028 maturity with an exit fee. June covenant compliance is historical; it does not guarantee future compliance or refinancing on acceptable terms.
The2026 convertible hasUSD21.835m face principal, an8% cash coupon and higher PIK rates, with aUSD0.87 conversion price. ExistingUnionChill consideration and derivative components require debt-or-dilution treatment; do not subtract debt and also assume full conversion of the same claim.
The original filed equity table gives385.617889m common equivalents. This includes preferred/exchangeable economics beyond309.175647m common shares, before incremental awards and convertibles; the release’s rounded basic description is not a fully diluted denominator.
H1 cash generation is helped byUSD20.439m changes in income taxes paid/tax-related liabilities, while the balance sheet carriesUSD152.547m uncertain tax position. Do not extrapolate cash flow as if disputed taxes have disappeared.
Continuing EBITDA excludesMichigan, while some cash and disposal outcomes include discontinued operations. Do not mix scopes. Potential acquisitions, minority interests and any implemented share consolidation require a fresh waterfall and adjustment basis.
Valuation and financing bridge
Conditional continuing-operations EV/EBITDA sensitivity; diluted equity waterfall held
Sourced anchors and model inputs
Company q2 continuing adjusted EBITDA USD million
17.661
Q2 annualized arithmetic reference USD million
70.644
Historical reference source id
TSND-RELEASE
Assumption label
CIN-selected next12-month sensitivity, not issuer guidance or consensus
Cash, debt, leases, minority and diluted-equity treatment
Bridge date
2026-06-30
Cash USD million
42.026
Loans face priNCIpal USD million
209.682
Convertible face USD million
30.835
Exit fee not in loan priNCIpal
1
Operating lease pv USD million
30.067
Uncertain tax liability USD million
152.547
NCI book USD million
4.426
June30 common equivalents before incremental dilution
385,617,889
Current share denominator
Unavailable
Equity bridge complete
0
CIN scenarios — assumptions, not company guidance
All forecast inputs and selected multiples below are CIN assumptions. Monetary bridge amounts are in the stated currency and units; per-share values are identified separately. Conditional values in NotRated cases are not current price targets.
Model line / unit
Bear
Base
Bull
Annual EBITDA USD million
60
70
80
Selected EV EBITDA multiple
4
5
6
Enterprise value USD million
240
350
480
Equity value USD million
Unavailable
Unavailable
Unavailable
Per share value
Unavailable
Unavailable
Unavailable
Scope
TerrAscend continuing operations; noMichigan recovery or future acquisition assumed
TerrAscend continuing operations; noMichigan recovery or future acquisition assumed
TerrAscend continuing operations; noMichigan recovery or future acquisition assumed
Label
Conditional business-value sensitivity; not a share-price target
Conditional business-value sensitivity; not a share-price target
Conditional business-value sensitivity; not a share-price target
CIN assumptions
USD60/70/80m annual EBITDA at4/5/6x gives USD240/350/480m business EVs before debt, convertible, tax, minority and exit-fee claims.
Selected multiples are a CIN stress framework, not a peer-derived median. Continuing cash and earnings scope must match.
Operating rent remains in this operating framework. The operating lease PV is disclosed for stress and cannot automatically be deducted twice.
Treat each convertible either as debt with its interest/exit claims or as converted with appropriate units and cash effects, never both.
Model limits and missing proof
Current face-debt/exit-fee/convertible and fully diluted share bridge not complete
Tax and minority cash claims must be valued; book amounts are not automatic settlement values
Actual post-authorization split/listing actions and compatible native-currency quote remain unverified
Next tests and thesis breakers
Original Q3 accounts with a continuing/discontinued cash reconciliation and an updated debt, tax and minority bridge.
Actual repayment, refinancing or conversion events, including whether debenture interest is cash or PIK.
A dated exchange notice if a specific share-consolidation ratio or seniorUS listing is implemented; authorization alone does not change the model.
NewJersey acquisition closing, verified consideration and integration results, distinct from management’s stated revenue opportunity.
Author holdings, issuer relationships/payments, recent or intended trades and conflicts have not been disclosed. They are not recorded as “none.”
CIN original research · IIPR
Innovative Industrial Properties, Inc.
NYSE · USD
NotRated · target withheld
High risk · unissued draft Model date 2026-10-23
Listing identity and market-data check
Legal entity
Maryland corporation; CIK1677576
Security
NYSE common stock, par0.001; NOT IIPR-PA/SeriesA or proposed SeriesB preferred
Country
US
Cannabis exposure
Direct property/tenant exposure to state-licensed cannabis businesses; also material non-cannabis life-science financial investments. Not a pure cannabis rent portfolio.
Source ids
IIPR-Q2; IIPR-PROSPECTUS
Share basis
Sep30 common27,570,861; no split inferred from authorized-share increase. Initial exchange69.39 is subject to adjustments not independently rolled forward.
Ticker
IIPR
Exchange
NYSE
Price
54.21
Currency
USD
As of
2026-10-23T20:00:00Z
Basis
Existing native persisted market quote supplied by root; not official exchange-close verification
Qualified for target
0
Current gate: June accounts precede material September/October investment and preferred financing. Conditional values are model illustrations; final cash, draws, preferred settlement and current diluted share/settlement basis are not reconciled well enough to issue a current target.
The equity case depends on rent collection and asset recoveries, not the quoted dividend alone. H1 operating cash did not cover the common dividends paid before preferred distributions and improvements.
The additional Alewife financing is large relative to June liquidity and expands exposure to one life-science sponsor. Its collateral/enforcement position differs from owned cannabis real estate.
The SeriesB financing has an annual preferred claim ahead of common equity. Authorized shares are not outstanding shares, and the June balance sheet cannot be relabeled current.
A modeled asset bridge produces useful conditional values, but completing the funding and liability rollforward is necessary before a current CIN opinion.
Principal risks and downside mechanism
Cannabis tenant defaults, downtime and costly re-leasing; July Parallel defaults involved two Florida leases representing about6.1% of June contractual rent.
IQHQ credit, construction, lease-up, and collateral-priority concentration; promised returns are not realized recovery.
SeriesB closing/over-allotment and subsequent draws/ATM activity are not reconciled to final current cash and capitalization.
Exchangeable-note settlement elections and adjusted exchange rates can change cash financing versus dilution.
Common distributions may change; the prior1.90 quarterly declaration is not a guaranteed forward cash return.
Valuation and financing bridge
Conditional asset SOTP: capitalized cannabis cash NOI after corporate costs + risk-weighted life-science/loan assets + target cash - gross debt - preferred liquidation claims; not an issued12month target.
Sourced anchors and model inputs
Reported cash USD million
204.734
Reported gross debt USD million
623.601
Series a liquidation claim USD million
141.65205
Modeled series b claim USD million
50
Existing life science carrying USD million
275.888
Modeled full new alewife asset USD million
245
Seller loans USD million
71.8
Minimum cash USD million
25
Cash, debt, leases, minority and diluted-equity treatment
The full245m new Alewife asset and cash outflow are both modeled;111m was actually advanced, the remaining134m remains conditional.
Assumed48.1m SeriesB proceeds are matched with50m preference; no free financing gain. Closing and the option remain unverified.
CIN liquidity leakage25/10/0m is AFTER operating cash, borrowing interest, all preferred/common dividends and ordinary cash costs; additional financing restores25m minimum cash.
Improvement commitments6.3m are funded once; ordinary tenant deposits/payables are not treated as spendable equity.
Bull only assumes full note conversion:402.5m is removed from debt while5.80054825m units are added. Bear/base deduct the debt and do not add conversion units.
No separate book NCI claim: issuer owns100% of operating partnership; investment recoveries are only the issuer assets, not the entire IQHQ company.
CIN scenarios — assumptions, not company guidance
All forecast inputs and selected multiples below are CIN assumptions. Monetary bridge amounts are in the stated currency and units; per-share values are identified separately. Conditional values in NotRated cases are not current price targets.
Model line / unit
bear
base
bull
Cannabis cash noi after corporate costs USD million
160
185
210
Selected cap rate
0.12
0.1
0.085
Cannabis property EV USD million
1,333.3333
1,850
2,470.5882
Modeled life science asset anchor USD million
520.888
520.888
520.888
Life science recovery fraction
0.5
0.75
1
Life science value USD million
260.444
390.666
520.888
Seller loan value USD million
57.44
64.62
71.8
Interim cash leakage after operating cash and all dividends USD million
25
10
0
Assumed series b net proceeds USD million
48.1
48.1
48.1
Modeled new alewife funding USD million
245
245
245
Improvement commitments funded USD million
6.3
6.3
6.3
Cash before gap funding USD million
-23.466
-8.466
1.534
Incremental debt for minimum cash USD million
48.466
33.466
23.466
Ending cash USD million
25
25
25
Ending gross debt USD million
672.067
657.067
244.567
Preferred liquidation claim USD million
191.6521
191.6521
191.6521
If converted equivalent units m
0
0
5.8005
Diluted units m
30
29
34.8005
Equity value USD million
812.4983
1,481.567
2,652.0572
Conditional value per equivalent share usd
27.0833
51.0885
76.2073
CIN assumptions
NOI, cap rates, recovery percentages, liquidity leakage and future29-30m common-equivalent units are CIN judgments, not issuer forecasts or peer medians.
Cash NOI excludes life-science income because those investments are separately valued as assets. No AFFO multiple is added on top of this SOTP.
Restricted cash2.903m is excluded. SeriesA is valued at25/share liquidation preference, not its128.995m accounting carrying amount.
Model limits and missing proof
Current funded amount, SeriesB settlement/option, current debt/cash and complete awards/ATM ledger must be reconciled.
Cap rates and recoveries are not appraisals; liquidity financing is not a lender commitment.
Initial69.39 exchange price may have adjustments; the bull if-converted illustration is not proof of the applicable current ratio.
Next tests and thesis breakers
Next original Q3 accounts reconcile current financing, funded investment and cash collection.
Documented re-leasing or recoveries from delinquent tenants.
Verified Alewife funding, senior-loan extensions and sponsor cash repayments rather than stated commitment totals.
Author holdings, issuer relationships/payments, recent or intended trades and conflicts have not been disclosed. They are not recorded as “none.”
CIN original research · AAWH
Ascend Wellness Holdings, Inc.
OTCQX · USD
NotRated · target withheld
High risk · unissued draft Model date 2026-10-23
Listing identity and market-data check
Legal entity
Delaware corporation; ClassA common stock
Country
US
Security
OTCQX AAWH; CSE ClassA venue aliases appear as AAWH.U/AAWH-U.CN. The source financial statement currency does not by itself certify a quote currency on the other venue.
Source ids
AAWH-Q2; AAWH-RELEASE; AAWH-SPLIT
Share basis
ClassB converted/retiredMay4,2026; Aug28 shareholders authorized1:10-1:50 reverse split but Board timing/ratio remains discretionary. No implementation is established by the bounded later news/8-K check.
Ticker
AAWH
Exchange
OTCQX
Price
0.4075
Currency
USD
As of
2026-10-23T19:50:00Z
Basis
Existing native persisted market quote supplied by root; not official exchange-close verification
Qualified for target
0
Current gate: Large tax/lease/financial claims and current award/split/financing uncertainties prevent a supported current equity target. Conditional stress values deliberately do not become a Sell rating or a zero target.
Sequential improvement and new stores are useful operating evidence, but cash generation available to equity is much smaller than adjusted EBITDA.
The central underwriting task is debt, long-dated finance leases and historical tax exposures. A simple debt-minus-cash calculation omits large senior claims.
A reverse-split authorization is not an implemented corporate action or proof of an exchange uplisting. It creates a future quote/share-basis reconciliation gate.
Base operating assumptions leave limited free cash after financing costs; large upside scenarios require stronger earnings and capital availability, not automatic tax forgiveness.
Principal risks and downside mechanism
High cash financing costs; H1 bank cash interest19.367m, finance-lease interest17.708m and other financing interest1.284m are separate.
214.487m uncertain-tax reserve and47.419m disclosed interest/penalties need allocation and settlement analysis; no reserve release is assumed in the bridge.
Potential gap equity at0.25 is a CIN funding illustration, not executable or board-approved financing.
VIE/partner dispensary economics are not equivalent to wholly owned store counts; expansion can require acquisition payments.
Potential future split, August option grants and ongoing awards prevent treating June diluted EPS shares as a current economic denominator.
Valuation and financing bridge
Conditional enterprise EBITDA value less gross financial debt, finance/failed-sale-leaseback claims, historical tax reserve, research-payment and minority claims; after operating rent.
Sourced anchors and model inputs
Starting cash USD million
67
Gross debt USD million
334.361
Finance other lease claim USD million
273.368
Historic tax reserve USD million
214.487
Broad share anchor m
226.137781
Modeled initial future units m
230
Minimum cash USD million
20
Cash, debt, leases, minority and diluted-equity treatment
Bank interest is separate from finance-lease and failed-sale-leaseback interest; all three are subtracted from EBITDA for cash forecasting.
Ordinary operating rent remains in forecast EBITDA;63.086m operating-lease PV is disclosed but not deducted again. Finance/other lease273.368m is an explicit capital claim.
Historic214.487m tax reserve remains outstanding in all cases. The47.419m interest/penalties disclosure is not mechanically added again because exact classification/overlap remains unresolved. This uncertainty is an issue gate.
Debt principal25.328m and finance-lease principal1.038m reduce both cash and corresponding claims; no double deduction from equity.
Academic research-payment balance6.236m is a separate contingent cash claim; minority2m is CIN economic judgment, not book NCI0.823m credited as cash.
Broad pre-split units use203.212781m Aug10 common +11.964m June options +6.337m August options +1.624m RSUs +3m approved but not-yet-granted performance award =226.137781m;230m model adds a conservative reserve, without exercise proceeds.
CIN scenarios — assumptions, not company guidance
All forecast inputs and selected multiples below are CIN assumptions. Monetary bridge amounts are in the stated currency and units; per-share values are identified separately. Conditional values in NotRated cases are not current price targets.
Model line / unit
bear
base
bull
Revenue USD million
450
500
550
After operating rent EBITDA USD million
90
120
145
Selected multiple
4
5.5
7
Enterprise value USD million
360
660
1,015
Bank cash interest USD million
38
40
42
Finance lease cash interest USD million
35.4
35.4
35.4
Other finaNCIng interest USD million
2.6
2.6
2.6
Current year cash tax USD million
20
15
10
Capex USD million
18
20
22
Working capital use USD million
10
5
0
FCF before priNCIpal and historic tax claim USD million
-34
2
33
Debt priNCIpal paid USD million
25.328
25.328
25.328
Finance lease priNCIpal paid USD million
1.038
1.038
1.038
New equity gap cash USD million
13.366
0
0
Assumed equity issue price usd
0.25
0.25
0.25
Target cash USD million
20
42.634
73.634
Target gross debt USD million
309.033
309.033
309.033
Target finance other lease claim USD million
272.33
272.33
272.33
Historic uncertain tax claim USD million
214.487
214.487
214.487
Academic research payment claim USD million
6.236
6.236
6.236
Minority economic claim cin judgment USD million
2
2
2
Diluted units m
283.464
230
230
Residual equity before floor USD million
-424.086
-101.452
284.548
Equity value USD million
0
0
284.548
Conditional value per share usd
0
0
1.2372
CIN assumptions
90/120/145m EBITDA and4/5.5/7x enterprise multiples are CIN judgments, not guidance or peer medians.
Current-year tax, capex, working capital and financing assumptions are distinct from historic tax claims; historical reserve payments/settlements are not forecast as completed.
Finance-lease interest/principal use explicit illustrative run rates and an unchanged liability except principal; new leases/renewals are not a verified forecast.
Model limits and missing proof
No issued target while reserve allocation, current cash/lease/debt/awards and split action status are not fully reconciled.
The zero residual in bear/base is a model floor, not a prediction of imminent insolvency, security cancellation or a quoted fair price.
Next tests and thesis breakers
Q3 filing with a reconciled current cash/debt/tax/lease bridge.
Verified medical/adult-use tax allocation and actual tax settlement cash rather than inferred broad tax relief.
Store ramps and working-capital conversion measured in operating cash.
A Board notice specifying any actual split ratio/effective date and a verified resulting quote basis.
Author holdings, issuer relationships/payments, recent or intended trades and conflicts have not been disclosed. They are not recorded as “none.”
CIN original research · MRMD
MariMed Inc.
OTCQB · USD
NotRated · target withheld
High risk · unissued draft Model date 2026-10-23
Listing identity and market-data check
Legal entity
Delaware corporation; CIK1522767
Country
US
Security
Common stock; original Aug12 and Sep23 releases identify OTCQB:MRMD and separate CSE:MRMD.
Cannabis exposure
US state-licensed cultivation, processing, branded cannabis wholesale and retail; cannabis license/brand counterparties, not open demand.
Source ids
MRMD-Q2; MRMD-RELEASE; MRMD-PROXY
Directory cleanup
Reviewed directory saysOTCQX; current original issuer sources sayOTCQB. Use the source-backed case identity and hold original QX-labeled quote pending feed mapping. FinancialFilings countryCA conflicts with Delaware issuer filing; do not copy catalog country.
Share basis
Proposed1:50–1:100 split vote is scheduledOct28, after this model cutoff; no implemented split is inferred.
Stored quote held
price 0.0534; currency USD; as of 2026-10-23T19:55:00Z; reason Directory/quote venueOTCQX versus primary issuerOTCQB; current same-security quote mapping needs reconciliation.
Not established in this review.
Current gate: Correct OTCQB identity differs from the saved feed venue, while taxes, restricted cash, amended preferred claims, current awards and pending split actions remain material. No supported current quote-adjusted price target is issued.
Branded-product and retail growth is observable, but higher sales did not prevent a wider quarterly common-stockholder loss.
H1 positive operating cash is weaker than a headline suggests: income-tax payables rose4.566m, more than the3.168m operating cash generated. That is financing through unpaid liabilities, not a repeatable margin improvement.
The preferred restructuring replaced one claim with new debt plus an amended preference; it did not erase all claims ahead of common shareholders.
Cash security must be evaluated after excluding restricted funds and allowing for current taxes, debt service and potential equity dilution.
Principal risks and downside mechanism
Tax payables materially exceed unrestricted cash; cash settlement schedule and any enforceable payment arrangements are not reconciled.
Current OCTQB versus stale OTCQX mapping prevents a verified same-listing target comparison.
June options have about four months weighted remaining life; present expiry/forfeiture exercises cannot be assumed without a current ledger.
The pending reverse split could change price/share units; October28 approval and any implementation must remain distinct.
Related-party supply purchases and product royalty arrangements require conflicts review; negative book NCI is not a cash asset.
Valuation and financing bridge
Conditional after-operating-rent enterprise EBITDA bridge, gross note/finance lease and historic tax claims, senior preference claim and positive NCI assumption; not a qualified target.
Sourced anchors and model inputs
Gross debt derived USD million
82.672
Gross debt derivation
Note9 expressly reports82.672m future principal less3.856m discount/fees=78.816m carrying; use the reported aggregate rather than summing rounded component discounts. Current rollforward remains unverified.
Starting unrestricted cash approx USD million
6.537
Cash derivation
8.437m total less issuer rounded1.9m restricted; precision is illustrative, not an exact bank reconciliation.
Historic income tax claim USD million
31.547
Base broad units before new gap funding m
461.947946
Cash, debt, leases, minority and diluted-equity treatment
Separate7.5m borrowing interest and0.5m finance-lease interest are CIN estimates. Operating rent stays in EBITDA;8.509m operating-lease PV is not also subtracted.
Existing31.547m taxes are held as a separate historical claim; forward cash tax estimates apply only to new-year operations and do not prove historical settlement.
Debt and finance-lease principal reduce both cash and claims. Preference is6.725m cash/liquidation claim; the26.9m preferred units are therefore NOT added again. A conversion case would need removal of the preference claim.
Broad common anchor403.040674m +10.692415m June RSUs +17.065921m June options +21.148936m warrants =451.947946m; add10m CIN new-award reserve. Some June RSUs may already be in cover shares and options may expire: conservative overcount, not certified currentFD.
Additional equity at0.04 is hypothetical gap funding; the bear broad share footprint exceeds current700m authorized common and is not executable without additional actions.
CIN scenarios — assumptions, not company guidance
All forecast inputs and selected multiples below are CIN assumptions. Monetary bridge amounts are in the stated currency and units; per-share values are identified separately. Conditional values in NotRated cases are not current price targets.
Model line / unit
bear
base
bull
Revenue USD million
160
180
205
After operating rent EBITDA USD million
12
18
26
Selected multiple
4
5.5
7
Enterprise value USD million
48
99
182
Bank note cash interest USD million
7.5
7.5
7.5
Finance lease cash interest USD million
0.5
0.5
0.5
Current year cash tax USD million
7
6
5
Capex USD million
3
3
4
Working capital use USD million
2
0
-1
FCF before priNCIpal and historic tax claim USD million
-8
1
10
Gross debt priNCIpal paid USD million
3.417
3.417
3.417
Finance lease priNCIpal paid USD million
1.934
1.934
1.934
New equity gap cash USD million
9.814
0.814
0
Assumed issue price usd
0.04
0.04
0.04
Ending cash USD million
3
3
11.186
Ending gross debt USD million
79.255
79.255
79.255
Ending finance lease claim USD million
1.42
1.42
1.42
Historic income tax claim USD million
31.547
31.547
31.547
New series b preference claim USD million
6.725
6.725
6.725
NCI cin economic claim USD million
2
2
2
Diluted units m
707.2979
482.2979
461.9479
Residual equity before floor USD million
-69.947
-18.947
72.239
Equity value USD million
0
0
72.239
Conditional value per share usd
0
0
0.1564
CIN assumptions
12/18/26m EBITDA,4/5.5/7x multiples, financing/tax/capex assumptions and minority2m claim are CIN judgments. No provider target or peer median is used.
No exercise cash or presumed preferred conversion. Negative book NCI is not credited. No tax relief or vote outcome is fabricated.
Model limits and missing proof
Pending split, OTCQB quote mapping, current awards/expiry and tax/payment/financing bridge prevent an issued current opinion.
Conditional zero values in bear/base are residual-equity floors, not a zero stock-price forecast or an insolvency conclusion.
Next tests and thesis breakers
October28 special meeting and any actual implementation notice, without assuming an uplisting.
Original Q3 cash/tax/debt statements; issuer schedules November12 conference call.
Verified cash margins and licensing growth that do not depend on stretching tax payables.
A reconciled current award/preference/capital table and correct OTC quote mapping.
Author holdings, issuer relationships/payments, recent or intended trades and conflicts have not been disclosed. They are not recorded as “none.”
CIN original research · MAPS
WM Technology, Inc. (Weedmaps)
OTCQX · USD
NotRated · target withheld
High risk · unissued draft Model date 2026-10-23
Listing identity and market-data check
Legal entity
Delaware corporation; CIK1779474
Country
US
Security
ClassA common stock. ClassV shares are paired with WMH LLC units and carry different direct economic rights; do not treat as a second freely quoted ClassA listing.
Cannabis exposure
Cannabis marketplace, advertising, ecommerce and compliance software, not a licensed plant producer.
Source ids
MAPS-Q2; MAPS-DELIST; MAPS-RELEASE
Directory cleanup
NASDAQ classification is stale: Form25 filedApr17, Nasdaq removal effectiveApr24; ClassA began OTCQXApr27. Public and private warrants expiredJun16, public warrants ceasedOTCIDtradingJun17.
Share basis
Aug3 ClassA112,498,797 and ClassV47,852,652; ClassV paired interests exchange1:1 subjectadjustment, ClassP/RSU/potential awards still require current reconciliation.
Not established in this review.
Current gate: Nasdaq identity is stale, no corrected current quote is available, and the Up-C/TRA/ClassP capital bridge remains incomplete. Source-verified research can be added while the current rating/target stays NotRated.
The listing change is a real coverage-cleanup issue. Nasdaq venue/quote assumptions cannot be reused after the company moved its ClassA common to OTCQX.
The marketplace retains substantial cash and reported profitability, but revenue declined and H1 cash generation did not cover capitalized software expenditure before financing flows.
Receivable growth and credit-loss provisions matter as much as headline EBITDA; removing noncash costs is not evidence all revenue will be collected.
The Up-C structure and tax receivable agreement require an economic ownership bridge. A nil recorded tax-receivable liability is not a blanket waiver of future obligations.
Principal risks and downside mechanism
No compatible current quote has been supplied for the corrected OTCQX listing; liquidity and eventual deregistration/disclosure constraints matter.
ClassP units, RSUs, future equity awards and tax-receivable economics are not fully reconciled to a current all-equivalent share count.
Cannabis-client concentration and bad-debt collection can impair cash conversion.
Pending litigation settlement approval and insurance recovery can change company cash obligations.
Commercial growth from AI initiatives is not established by their effect on cloud-spending estimates.
Valuation and financing bridge
Conditional consolidated after-operating-rent EBITDA value plus cash, less explicit litigation payment and discretionary futureTRA stress, divided by modeled all-common-equivalent Up-C units. Not a current target.
Sourced anchors and model inputs
Cash USD million
60.499
Reported finaNCIal debt USD million
0
Operating lease liability disclosed USD million
24.661
Reported classA plus paired ClassV anchor m
160.351449
Recorded TRA claim USD million
0
Litigation cash proxy USD million
2.4
Cash, debt, leases, minority and diluted-equity treatment
Ordinary operating rent remains in EBITDA and forecast cash;24.661m operating-lease PV is not subtracted again.
No financial borrowing appears in the June balance sheet;0 is a dated observation, not a verified current no-debt statement.
All equivalent units notionally include ClassA plus pairedClassV/LLC economics; book NCI76.007m is therefore not subtracted again. ClassP and award uncertainty makes165/170/175m denominators CIN assumptions, not verified FD counts.
2.4m company settlement is deducted once from cash; the full7.5m gross proposed settlement is not also deducted because5.1m is expected from insurers, subject to conditions.
TRA20/10/0m stress claims are explicit CIN conservatism, not source-reported liability. The issuer hypothetical136.2m future obligation is not treated as current debt; valuation also gives no value to the corresponding uncertain future tax benefits.
CIN scenarios — assumptions, not company guidance
All forecast inputs and selected multiples below are CIN assumptions. Monetary bridge amounts are in the stated currency and units; per-share values are identified separately. Conditional values in NotRated cases are not current price targets.
Model line / unit
bear
base
bull
After operating rent EBITDA USD million
8
15
25
Selected multiple
4
6
8
Enterprise value USD million
32
90
200
Current year cash tax USD million
1
1
2
Capitalized software capex USD million
14
14
15
Working capital use USD million
3
1
-1
FCF before litigation payment USD million
-10
-1
9
Assumed litigation cash payment USD million
2.4
2.4
2.4
Ending cash USD million
48.099
57.099
67.099
FinaNCIal debt assumed USD million
0
0
0
Additional TRA stress claim cin judgment USD million
20
10
0
Equity value all equivalent units USD million
60.099
137.099
267.099
All equivalent units m
175
170
165
Conditional value per equivalent unit usd
0.3434
0.8065
1.6188
CIN assumptions
8/15/25m EBITDA and4/6/8x multiples are CIN judgments; company forecast or a peer median is not asserted.
Capitalized development14/14/15m, tax, collections and settlement assumptions are forward scenarios, not verified payments.
Model limits and missing proof
No current same-listing quote and no complete current economic denominator/TRA bridge; public rating and price target remain withheld.
Expired warrants must not revive as outstanding dilution. Conditional all-unit values are not targets for the old Nasdaq listing.
Next tests and thesis breakers
A verified same-security OTCQX quote and current SEC/issuer capital table.
Original next accounts demonstrate cash conversion after software investment and sustainable client retention.
Court approval and actual cash/insurance settlement of disclosed litigation.
Reconciliation of potential future tax benefits, TRA obligations and ClassP exchange rights.
The retained VRNO observation has a legacy Class A label. The reviewed common-stock identity and split are verified, but an independent current same-security quote/class/post-split mapping is not established. A bounded official OTC overview read yielded only an application shell; no quote was inferred.
Current gate: NotRated: the conditional equity model is reproducible, but the current same-security post-split quote mapping remains unverified. June-to-horizon cash, tax settlement and future units are assumptions. USD4.03 base (USD4.00 rounded) is conditional model value only, not a CIN target or a Sell recommendation.
Revenue recovered, but Q2 gross margin fell to45.75% from55.86% and operating income fell sharply. Revenue growth alone does not establish shareholder cash conversion.
The base assumes USD200m forward annual after-rent adjusted EBITDA at5x, broadly near the reported H1 run-rate. Both forecast and selected multiple are CIN judgments, not external consensus or observed peer medians.
Reserve the entire USD400.743m reported uncertain-tax claim in the base. Historic tax cash payments are far below the prior-year period; treating all accrued tax uncertainty as free equity would overstate value. No prospective federal reform or tax forgiveness is credited.
The March2026 refinancing retired the old October2026 term maturity. Current term debt/revolver mature in2029. The research therefore focuses on economics and tax claims rather than asserting an obsolete imminent refinancing crisis.
Principal risks and downside mechanism
A favorable tax resolution can materially exceed this conservative base; penalties or adverse settlement can be worse. A carrying liability is not a forecast settlement payment or timing.
Medical/adult-use tax allocation, future IRS guidance and legal challenges are unresolved. No claim is made that all adult-use federal issues are settled.
Forecast margin recovery, capex maintenance needs, working capital and minority economics remain judgments. Cash balances are June30 observations, not certified October cash.
Failure to maintain credit minimum-cash/fixed-charge covenants or additional share awards can reduce equity value. Only June30 covenant compliance was reported.
Valuation and financing bridge
Conditional normalized annual operating run-rate at the twelve-month horizon, valued using after-rent EV/EBITDA and an explicit debt/cash/legacy-tax/minority/dilution bridge. The 480-day cash reconstruction from June 2026 to October 2027 is forward CIN judgment, not reported current cash. No current target or rating.
Sourced anchors and model inputs
Starting gross priNCIpal USD million
406.779
Starting cash USD million
85.195
Current debt annual paydown proxy USD million
10.548
Operating lease PV USD million
101.068
Source balance date
2026-06-30
Known equity awards footprint m
74.399672
Rounded conditional case value usd
4
Conditional exact base usd
4.02901
Cash, debt, leases, minority and diluted-equity treatment
Cumulative cash model runs exactly480days from June30,2026 to October23,2027. Annual cash=(EBITDA−gross cash interest−current tax cash−capex−working-capital use); multiply480/365 then subtract transition/execution reserve. This reconstructs the unreported intervening period prospectively; it is not actual current cash.
Principal proxy10.548m/year is paid out of cash and removed from gross debt together; no double benefit. Detailed mortgage amortization/actual October cash require refresh.
Common equity=operating EV+ending unrestricted cash−ending gross principal−legacy tax claim−positive NCI economic claim−0.042m acquisition payable; floor illustrative distressed equity atzero, not a bankruptcy prediction.
Debt interest is outside EBITDA. Operating rent remains inside the forecast, so the101.068m operating-lease PV is disclosed but not deducted again. Full-lease-PV stress lowers base by101.068/77=1.312571USD/share.
No preferred shares outstanding. 73.217970m current shares+1.176988m RSUs+0.004714m options=74.399672m known dated broad footprint; model80/77/76m future units adds further compensation reserves without fictional financing cash or buyback benefits.
Full base legacy UTP400.743m is separate from forecast current-year cash taxes; bull300m and bear450m are explicit settlement/penalty stresses, not observed or agreed outcomes. No refund receivable, held-for-sale asset, tax indemnity or future uplisting premium is credited.
CIN scenarios — assumptions, not company guidance
All forecast inputs and selected multiples below are CIN assumptions. Monetary bridge amounts are in the stated currency and units; per-share values are identified separately. Conditional values in NotRated cases are not current price targets.
Model line / unit
bear
base
bull
Forward annual after rent EBITDA USD million
170
200
230
Selected EV EBITDA x
4
5
6
Cash interest annual USD million
45
42
40
Current tax cash annual USD million
70
55
45
Capex annual USD million
50
45
40
Working capital cash use annual USD million
25
18
10
Annual cash before priNCIpal USD million
-20
40
95
Bridge days
480
480
480
Bridge years
1.3151
1.3151
1.3151
Transition execution cash reserve USD million
5
15
30
Cumulative cash change before priNCIpal USD million
-31.3014
37.6027
94.9315
PriNCIpal paydown USD million
13.8713
13.8713
13.8713
Ending cash USD million
40.0223
108.9264
166.2552
Ending gross priNCIpal USD million
392.9077
392.9077
392.9077
Legacy tax claim USD million
450
400.743
300
NCI economic claim USD million
8
5
3
Acquisition payable USD million
0.042
0.042
0.042
Future diluted units m
80
77
76
Operating EV USD million
680
1,000
1,380
Unfloored equity USD million
-130.9274
310.2337
850.3055
Modeled equity USD million
0
310.2337
850.3055
Modeled value usd per share
0
4.029
11.1882
CIN assumptions
All operating forecasts, multiples, cash taxes/interest, transition reserves, minority values and future units are CIN judgments.
USD42m base gross cash interest is modeled without an interest-income credit; H1 reported21.101m is net interest paid and is not relabeled gross.
NCI claim5m is an independent positive economic reserve, not the negative book balance treated as cash.
The exact conditional base is USD4.029 per modeled share, rounded to USD4.00 for review. This is not a qualified target, and no current price-return comparison or Buy/Hold/Sell conclusion is admitted.
Model limits and missing proof
The old stored Class A label is not corrected into a qualified post-split quote by ticker/exchange matching alone. Current rating, target and upside remain withheld until same-security mapping is supported.
High risk; full tax-liability reserve and June-to-horizon cash reconstruction dominate the wide range.
Refresh on scheduled October29 results, changed tax/covenant/capital evidence or a material share action. Source/model dates are not renewed.
This remains an unissued CIN working paper, not a final CIN recommendation or a qualified external consensus target. Author holdings and conflicts have not been disclosed; their absence is not inferred.
Next tests and thesis breakers
event Q3 results and current capital/tax reconciliation; date 2026-10-29; source id VRNO-NEXT; status issuer scheduled; no result inferred
event Tax guidance or settlement and current covenant updates; date Unavailable; status unresolved; re-underwrite rather than automatically renew target
Author holdings, issuer relationships/payments, recent or intended trades and conflicts have not been disclosed. They are not recorded as “none.”
CIN original research · VREOF
Vireo Growth Inc.
OTCQX · USD
NotRated · target withheld
High risk · unissued draft Model date 2026-10-23
Listing identity and market-data check
Security
Subordinate voting shares, OTCQX VREOF/USD; CSE VREO separate listing
Legal domicile
British Columbia, Canada
Split
1-for-30 effective June5,2026; Q2 share data already restated
Current ISIN
CA92767B2049
SVS as of Oct8
51,544,115
MVS as of Oct8
7,718
MVS conversion ratio
100
Total as converted Oct8
52,315,915
Source ids
VREO-Q2; VREO-S4; VREO-MEETING
Price
8.17
Currency
USD
As of
2026-10-23T19:59:00.000Z
Symbol
VREOF
Exchange
OTCQX
Basis
Existing stored observation; raw OTC label corrected to issuer-confirmed OTCQX; no current target comparison.
Current gate: Current pro forma cash, gross principal, finance/operating lease changes, tax claims, earnouts, convertible instruments and fully diluted SVS-equivalent units across the acquisition program are not reconciled. The stored quote alone cannot cure this equity-bridge gap.
Vireo is becoming a cannabis and agricultural-supply platform. Hawthorne sells growing supplies; Bridgewell supplies food/agricultural ingredients. Their revenue cannot be treated as organic cannabis growth.
Q2 growth reflects multiple acquisitions; non-GAAP EBITDA and a bargain-purchase gain do not remove cash-tax, lease and financing obligations.
October8 as-converted shares already exceed the August14 cover footprint; pending and subsequent deals add consideration, earnouts, debt and integration needs. A single old denominator would misprice common equity.
The October60m property loan replaces49m existing senior debt and funds property/costs. It is not60m incremental unrestricted cash; the disclosed41m second-lien original obligation must also be mapped rather than dropped.
Principal risks and downside mechanism
The June cash/debt/capital statement does not reconcile every closing through October23. Current net debt, undrawn-versus-funded ABL amounts, contingent consideration and all share/convertible equivalents are not verified.
Multiple voting shares convert100:1 into SVS. Ignoring this and the June30-for-1 action corrupts the denominator.
Planet13 is pending, not an already owned subsidiary. Prospective270-store statements depend on all announced closings and are not current store counts.
Valuation and financing bridge
Conditional enterprise-value sensitivity only; no common-equity or per-share target
Sourced anchors and model inputs
FinaNCIal snapshot date
2026-06-30
Dated book debt carrying sum USD million
322.4
Dated finance lease USD million
8.8
Dated operating lease USD million
154.6
Dated contingent consideration USD million
36.5
Dated tax claim USD million
172.8
Cash, debt, leases, minority and diluted-equity treatment
Gross-principal/current-cash/lease/earnout/share reconciliation is deliberately incomplete, so operating EV is not converted into equity.
Do not add60m Needham debt to June figures without removing the49m refinanced note and mapping collateral/property financing and second lien.
Restricted cash19.6m and indemnified tax assets48.8m are not unrestricted cash. No offset is assumed without recovery/support.
No separate balance-sheet NCI line was reported in the reviewed June statement; this does not prove the current joint-venture/minority claim is zero.
CIN scenarios — assumptions, not company guidance
All forecast inputs and selected multiples below are CIN assumptions. Monetary bridge amounts are in the stated currency and units; per-share values are identified separately. Conditional values in NotRated cases are not current price targets.
Model line / unit
bear
base
bull
Assumed forward after rent EBITDA USD million
150
200
260
Selected EV EBITDA x
4
5
6
Conditional operating EV USD million
600
1,000
1,560
Per share value
Unavailable
Unavailable
Unavailable
CIN assumptions
150/200/260m annual after-rent EBITDA and4/5/6x multiples are CIN stress assumptions, not forecasts certified by management, peer medians or estimates of per-share fair value.
Model limits and missing proof
NotRated; no target, upside or recommendation is produced.
Original sources are bounded captures, not a completed all-deal diligence exercise.
Next tests and thesis breakers
event Updated quarterly statements and all-deal capital/debt/lease bridge; date Unavailable; status required before a target
event Planet13 regulatory/shareholder/registration approvals; date Unavailable; source id VREO-S4; status pending in reviewed sources; no completed merger inferred
event Vireo special meeting; date 2027-01-06; source id VREO-MEETING; status meeting date only; purpose not inferred
Author holdings, issuer relationships/payments, recent or intended trades and conflicts have not been disclosed. They are not recorded as “none.”
CIN original research · PLNH
Planet 13 Holdings Inc.
OTCQX · USD
NotRated · target withheld
High risk · unissued draft Model date 2026-10-23
Listing identity and market-data check
Security
Nevada common stock; OTCQX PLNH/USD; CSE PLTH separate listing
Status as reviewed
Merger pending; current shares not assumed delisted or converted
Known common shares
335,319,455
Share date
2026-10-05 per S4
Exchange ratio
0.015384
Ratio security
Vireo subordinate voting share per Planet13 common share, subject to exclusions and closing
Source ids
PLNH-Q2; PLNH-MERGER; PLNH-S4; PLNH-OCT425
Price
0.095
Currency
USD
As of
2026-10-23
Exchange
OTCQX
Symbol
PLNH
Basis
Stored date-only observation; not synchronized with Vireo quote and not an executable deal spread.
Current gate: Pending stock merger and unresolved Vireo fully diluted/pro forma bridge preclude a supported12-month per-share target. Conditional contract math is not a CIN fair-value target; date-only PLNH quote cannot support an executable arbitrage spread.
Options as of June30 CAD4.37 strike, September30,2026 expiry; current exercise/expiry reconciliation required, not automatically included as current instruments
The California exit and cost reductions improved reported gross margin, but Q2 revenue fell and adjusted EBITDA remained negative. A reserve reversal is not recurring sales economics.
The equity is now a merger-dependent claim as well as a small standalone operator. The contractual ratio is fixed; Vireo’s own financing/capital path drives the consideration value.
A cash-and-restricted-cash headline16.5m masks only6.58m unrestricted cash and a9.75m collateralized revolver. Tax and lease claims are much larger than cash.
October9 registration and October21 Rule425 material still describe an uncompleted transaction. Do not call Planet13 already owned by Vireo or erase its current listing before verified close/delisting.
Principal risks and downside mechanism
Merger registration, shareholder and state approvals remain closing conditions. No probability or closing date is invented.
Fixed exchange ratio leaves Planet13 holders exposed to Vireo price dilution and market risk; no floor/collar is assumed.
Positive H1 CFO benefited from9.31m working-capital movement; before this movement and lease presentation it was negative. It is not evidence of durable free cash generation.
40.105m accrued uncertain-tax positions, note face, lease cash needs, potential awards and merger termination conditions can affect standalone recovery.
Valuation and financing bridge
Contractual exchange-ratio sensitivity plus standalone operating-EV stress; neither is a price target
Sourced anchors and model inputs
Exchange ratio
0.015384
Known Planet13 common shares
335,319,455
Vireo consideration shares for common only
5,158,426.403688
Contingent on close
1
Cash, debt, leases, minority and diluted-equity treatment
Contract value equals0.015383618×hypothetical Vireo share price; the5/8/12USD prices are CIN sensitivity inputs, not Vireo targets. No failure probability or executable spread is presented.
No conditional enterprise value is converted to common-equity value because the pending merger, current cash and all debt/tax/award claims need reconciliation.
Debt face=9.75m revolver+1.5m VidaCann note=11.25m, not11.015683m carrying debt. Match the9.9m restricted cash with collateral restrictions rather than subtracting cash-secured financing inconsistently.
44.149666m operating-lease PV is disclosed. After-rent operating sensitivities already include operating occupancy cost; do not automatically deduct PV again.
335.319455m basic common shares differ from GAAP weighted-average EPS units;11.369670m RSUs and18.750000m warrants require merger treatment. Expired September options are not certified current without register reconciliation.
CIN scenarios — assumptions, not company guidance
All forecast inputs and selected multiples below are CIN assumptions. Monetary bridge amounts are in the stated currency and units; per-share values are identified separately. Conditional values in NotRated cases are not current price targets.
Model line / unit
bear
base
bull
Hypothetical Vireo price usd
5
8
12
Conditional contract value per PLNH share usd
0.0769
0.1231
0.1846
Assumed standalone after rent EBITDA USD million
-3
1
5
Selected standalone EV EBITDA x
0
4
5
Conditional standalone operating EV USD million
0
4
25
Draft price target
Unavailable
Unavailable
Unavailable
CIN assumptions
All hypothetical prices, operating scenarios and multiples are explicitly conditional CIN arithmetic.
Model limits and missing proof
NotRated, targetnull, no upside; fairness opinion for a transaction is not a continuing broker recommendation or CIN target.
Next tests and thesis breakers
event Effective registration, vote and state approval status; date Unavailable; source id PLNH-S4; status not verified complete
event Actual merger completion and listing cessation notices; date Unavailable; status required before alias/status retirement
event Current standalone cash burn and capital table; date Unavailable; status needed for independent target
Author holdings, issuer relationships/payments, recent or intended trades and conflicts have not been disclosed. They are not recorded as “none.”
CIN original research · GLAS
Glass House Brands Inc.
NYSE · USD
NotRated · target withheld
High risk · unissued draft Model date 2026-10-23
Listing identity and market-data check
Security
Subordinate voting shares, NYSE GLAS/USD; Cboe Canada GLAS.A.U/USD separate listing
Legacy OTC symbol
GLASF
Legacy OTC ceased
2026-06-29 close
NYSE start
2026-06-30
Multiple voting shares
4,754,979 June30:50votes each, nonconvertible/no dividends; do not add one-for-one to common economic denominator
Exchangeable shares
6,244,521 June30 are economically equivalent to common and cannot be omitted
Source ids
GLAS-Q2; GLAS-MDA; GLAS-ATM
Not established in this review.
Current gate: No compatible current NYSE GLAS quote is supplied, and June capital must be rolled through ATM issuance, exercised warrants, compensation, preferred/convertible claims and the changed retail perimeter. Preliminary cash does not provide a current unrestricted/full financing bridge.
Scale and production cost progress are real operating facts, but Q3 selling price fell much faster than production cost and preliminary gross margin remained under pressure. More pounds are not automatically more owner cash.
The June12 deconsolidation changes the perimeter. Continuing revenue must be compared with recast earnings, while management notes CFO comparatives still include GHR; do not mix those bases.
Preferred SeriesD/E face totals92.5m and stated annual cash-dividend run-rate is11.55m if declared. These claims sit ahead of common shareholders and are omitted by a simplistic EBITDA-minus-bank-debt target.
The source confirms NYSE GLAS; legacy GLASF is a retired OTC route. The old queue entry cannot accept a new ticker price without exact security migration and current capital verification.
Principal risks and downside mechanism
Latest cash39.7m is combined unrestricted/restricted and preliminary. ATM share estimates and gross-proceeds averages are rounded and cannot certify a fully diluted share register.
SeriesE may convert atUSD9 or retain senior preference/dividend economics. Modeling both the full preference deduction and full conversion dilution simultaneously double counts.
Cultivation, permitting, California price compression, capex and execution remain material. GACP certification and a first hemp sale do not themselves authorize unrestricted interstate or international cannabis trade.
A retained equity-method/option interest is not the same as consolidating the former retail EBITDA or receiving distributable cash.
Valuation and financing bridge
Conditional after-rent operating-EV sensitivity only; no common-equity or per-share target
Sourced anchors and model inputs
Dated notes carrying USD million
70.141
Dated finance lease PV USD million
0.58
Dated preference face USD million
92.5
Dated unrestricted cash USD million
18.554
June reported common equivalent m
89.045008
Cash, debt, leases, minority and diluted-equity treatment
Operating EV0/100/240m precedes gross-principal, preference, derivative/convertible, current cash, future capital spending and fully diluted unit reconciliation.
Do not use70.141m carrying notes as certified current principal; June preferred92.5m has senior claims and accrued dividend provisions.
SeriesE77.5m atUSD9 implies8.611111m potential common equivalents if fully converted, but conversion scenarios must remove the same preference cash claim.
Multiple voting shares are governance units without common dividend/conversion economics; exchangeable shares are economic equivalents. Current option/RSU/ATM register remains required.
The no-warrants statement is datedJuly23 after full exercise; the newly issued shares must be included rather than retaining both warrants and shares.
CIN scenarios — assumptions, not company guidance
All forecast inputs and selected multiples below are CIN assumptions. Monetary bridge amounts are in the stated currency and units; per-share values are identified separately. Conditional values in NotRated cases are not current price targets.
Model line / unit
bear
base
bull
Assumed forward after rent EBITDA USD million
0
20
40
Selected EV EBITDA x
0
5
6
Conditional operating EV USD million
0
100
240
Per share value
Unavailable
Unavailable
Unavailable
CIN assumptions
Annual forward after-rent EBITDA0/20/40m and0/5/6x are CIN stress assumptions, not source forecasts or targets.
No legal-route clearance, future export earnings or tax forgiveness is assumed.
Model limits and missing proof
NotRated; no target/upside. A broken retired ticker does not imply the issuer lacks current filings or operating value.
Next tests and thesis breakers
event Final Q3 statements with unrestricted cash and capital table; date Unavailable; status not yet reviewed; required
event Evidence of cash generation after capex/preferred dividends; date Unavailable; status management aspiration, not achieved by reported negative Q3 CFO
event Current exchange/security and price verification for GLAS; date Unavailable; status no compatible dated current quote supplied in this lane